Compound Buyer is the independent UK editorial review of who is selling research peptides in Britain, and how well. Every company we cover goes through the same five checks. No advertising, no affiliate fees, no exceptions.
A sceptical read of the BPC-157 literature in 2026. What the preclinical research describes, where the human evidence is missing, and what an honest research-peptide buyer should take from the published record.
Read the feature →
Our cover essay, and the piece we send to readers who write in asking where to start. The five things we have found, after several months of supplier correspondence, that actually separate a serious peptide company from a presentable one.
Read the guide →
A year in regulation, supply, the GLP-1 spillover and the new molecules. What changed in the British research-peptide market in 2025, and what to watch in 2026.
Read the feature →
Our most thorough single piece. Anglopeptides, Black & White Peptides, Proforma Peptides, Revion and UK Peptides, scored against the same six-point framework, with strengths and watch-outs for each laid out in full.
See the comparison →
What the term actually means, how the compounds are supplied and stored, and why purity testing matters.
What a good CoA contains, how to spot a reused one, and how to verify it independently.
What lab accreditation actually guarantees, and how to check a peptide testing lab in the UK.
The legal framework behind every UK peptide page, and the roles of MHRA, ASA and Trading Standards.
A short Thursday letter from the desk: supplier checks that did not warrant a full piece, regulatory notes worth flagging, and the occasional correction. No tracking, no sponsors, free to read.